These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3936359)

  • 41. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
    Green D; Rademaker AW; Briët E
    Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acquired factor VIII inhibitors--successful treatment with an oral outpatient regimen.
    Bayer RL; Lichtman SM; Allen SL; Budman DR; Buchbinder A; Fetten J; Kolitz J; Loscalzo J
    Am J Hematol; 1999 Jan; 60(1):70-1. PubMed ID: 9883809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired factor VIII inhibitor in a patient with malignant lymphoma.
    Wenz B; Friedman G
    Am J Med Sci; 1974 Nov; 268(5):295-9. PubMed ID: 4617504
    [No Abstract]   [Full Text] [Related]  

  • 44. Long-lasting remission and successful treatment of acquired factor VIII inhibitors using cyclophosphamide in a patient with systemic lupus erythematosus.
    Trotta F; Bajocchi G; La Corte R; Moratelli S; Sun LY
    Rheumatology (Oxford); 1999 Oct; 38(10):1007-9. PubMed ID: 10534554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Presentation and management of a stage Ia lung cancer patient with a paraneoplastic factor VIII inhibitor.
    Laselle BT; Boggio LN; Blum MG
    Ann Thorac Surg; 2006 Jan; 81(1):362-4. PubMed ID: 16368409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Enhanced activity of diminished blood clotting factors in inborn blood coagulation defects].
    Mingers AM; Mietens C; Ströder J
    Thromb Diath Haemorrh; 1971 Jun; 25(2):316-31. PubMed ID: 5568051
    [No Abstract]   [Full Text] [Related]  

  • 47. Circulating anticoagulants.
    Zieve PD; Levin J
    Major Probl Intern Med; 1976; 10():65-70. PubMed ID: 785117
    [No Abstract]   [Full Text] [Related]  

  • 48. CIRCULATING ANTICOAGULANT AGAINST FACTOR 8 COEXISTENT WITH SOME IMMUNOLOGICAL REACTIONS IN A FEMALE.
    LOPACIUK S; NALECZYNSKA A; CZAJA H; WALEWSKA I; PAWELSKI S
    Thromb Diath Haemorrh; 1964 Jul; 11():444-51. PubMed ID: 14194113
    [No Abstract]   [Full Text] [Related]  

  • 49. Combined factor VIII and IX inhibitors in a non-haemophilic patient: successful treatment with immunosuppressive drugs.
    Carmassi F; Giannarelli C; De Giorgi A; De Negri F
    Haemophilia; 2007 Jan; 13(1):106-7. PubMed ID: 17212735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Plasma and plasma fractions in the therapy of blood coagulation disorders].
    Lechler E
    Internist (Berl); 1974 Sep; 15(9):461-4. PubMed ID: 4609113
    [No Abstract]   [Full Text] [Related]  

  • 51. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Circulating anticoagulant (antifactor 8 treated with immunosuppressive drugs.
    Sherman LA; Goldstein MA; Sise HS
    Thromb Diath Haemorrh; 1969 Apr; 21(2):249-58. PubMed ID: 5786668
    [No Abstract]   [Full Text] [Related]  

  • 53. Filling defects in the renal pelvis and ureter owing to bleeding secondary to acquired circulating anticoagulants.
    Eisenberg RL; Clark RE
    J Urol; 1976 Nov; 116(5):662-3. PubMed ID: 978826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Factor VIII inhibitors in non-hemophiliac patients. A report of cases and therapeutic prospects].
    Haupt E; Rolandelli ML; Bardellini G; Raffo A; Mencoboni M
    Clin Ter; 1991 Sep 15-30; 138(5-6):213-7. PubMed ID: 1836169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of plasmapheresis (PP), corticosteroids and cyclophosphamide in essential mixed polyclonal cryoglobulinaemia associated with glomerulonephritis.
    Houwert DA; Hené RJ; Struyvenberg A; Kater L
    Proc Eur Dial Transplant Assoc; 1980; 17():650-4. PubMed ID: 7243802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Corticosteroid therapy for acquired F VIII:C inhibitors.
    Spero JA; Lewis JH; Hasiba U
    Br J Haematol; 1981 Aug; 48(4):635-42. PubMed ID: 6791677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamide.
    Green D; Schuette PT; Wallace WH
    Arch Intern Med; 1980 Sep; 140(9):1232-5. PubMed ID: 6773487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb).
    Jansen M; Schmaldienst S; Banyai S; Quehenberger P; Pabinger I; Derfler K; Hörl WH; Knöbl P
    Br J Haematol; 2001 Jan; 112(1):91-7. PubMed ID: 11167789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Decreased helper/suppressor cell ratios after treatment with factor VIII and IX concentrates and fresh frozen plasma.
    Ragni MV; Lewis JH; Spero JA; Bontempo FA; Rabin BS
    Am J Med; 1984 Feb; 76(2):206-10. PubMed ID: 6230009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.